Peter Karellas

The Impact of Molecular Weight and PEG Chain Length on the Systemic Pharmacokinetics of PEGylated Poly <scp>l</scp>-Lysine Dendrimers

Lisa M. Kaminskas, Ben J. Boyd, Peter Karellas et al. · Molecular Pharmaceutics · 2008 · 177 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Structure Activity Relationship of Dendrimer Microbicides with Dual Action Antiviral Activity

David Tyssen, Scott Henderson, Adam Johnson et al. · PLoS ONE · 2010 · 172 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Cationic Poly- <scp>l</scp> -lysine Dendrimers:  Pharmacokinetics, Biodistribution, and Evidence for Metabolism and Bioresorption after Intravenous Administration to Rats

Ben J. Boyd, Lisa M. Kaminskas, Peter Karellas et al. · Molecular Pharmaceutics · 2006 · 163 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats

Lisa M. Kaminskas, Jagannath Kota, Victoria M. McLeod et al. · Journal of Controlled Release · 2009 · 144 citations

Pharmacy, Pharmaceutics, Pharmacology +12

Impact of Surface Derivatization of Poly-<scp>l</scp>-lysine Dendrimers with Anionic Arylsulfonate or Succinate Groups on Intravenous Pharmacokinetics and Disposition

Lisa M. Kaminskas, Ben J. Boyd, Peter Karellas et al. · Molecular Pharmaceutics · 2007 · 53 citations

Pharmacy, Pharmacokinetics, Pharmacology +13